Transcatheter aortic valve replacement in patients with systolic heart failure, aortic stenosis shows limited benefits
In patients with HFrEF and moderate AS, a complementary target for afterload reduction may be treatment of AS. However, ...
pharmaphorum3y
FDA gives breakthrough status to Biofourmis' heart failure DTx
BiovitalsHF uses software algorithms and wearable sensors to help direct drug treatment for HFrEF, encourage patients ... It has been designed to follow guideline-directed medical therapy ...